Our focus for this Therapeutics and Vaccine discussion includes an update on the treatment, and characterization, of Post-Acute Sequelae of SARS-CoV-2 infection (PASC) or long-COVID. As this condition develops in real time, we’re getting a clearer picture each day—and real-world data is providing the color, and texture, of that picture. To help us further develop our view Dr. Manesh Patel of Duke University will share Duke's experiences in integrating PASC identification and treatment into primary care and their efforts to better understand its incidence in athletes. Dr. Ethan Berke, Chief Public Health Officer at United HealthGroup, will share what they are seeing as both a payer and a provider to help us paint this picture, with brighter colors.